Y-box-1 protein (Yb-1) and breast cancer: Prognostic factor and target for therapy

A research group at the University of British Columbia (Vancouver) led by Sandy Dunn underlined the potential of Y-box-1 (YB-1) for the prognosis and therapy of breast cancer in two recent publications.
After analyzing more than 4049 samples the team comes to the conclusion, that a strong relationship exists between the occurrence of YB-1 and the risk of cancer relapse (See reference 1).

In addition the group shows that an inhibition of the / YB-1 triggers in aggressive tumor subtypes.

Related antibodies:

Polyclonal Y-box-1 antibodies

YB-1 (N-Term) (Human) antibodies

YB-1 (NLS) (C-Term) antibodies

Monoclonal Yb-1 antibodies for immunhistochemistry

Yb-1 antibodies (Monoclonal)